Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of XARTEMIS XR in Postsurgical Adolescents
NCT02508935Phase 4Terminated
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Nov 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oxycodone + acetaminophen in acute pain, sponsored by Mallinckrodt Pharmaceuticals. Started Nov 2015; status: terminated.
02
Drugs
oxycodone + acetaminophen
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT02508935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02508935.